FDA names drugmakers accused of blocking cheaper generics

TRENTON, N.J. — U.S. drug regulators are publicizing information on brand-name drugmakers that use what government officials call "gaming tactics" to block cheaper copycat versions.

The Food and Drug Administration's new webpage names the makers of more than 50 brand-name drugs, some carrying six-figure annual price tags, who are under scrutiny. The agency also lists how many inquiries it has received from generic drugmakers who say they are having trouble getting access to the brand-name drugs.

Generic drug companies generally require 1,000 to 1,500 units, such as pills, of a brand-name drug to create much-cheaper drugs with identical active ingredients and effects. The FDA says brand-name drugmakers sometimes refuse to sell generic companies drugs that may need extra safety monitoring or bar drug wholesalers from selling other medicines to generic drugmakers.

Related News

Rugby couple put respect in front and center in Olympics

Aug 10, 2016

Isadora Cerullo has become a celebrity around Rio, more for what happened on the sidelines of the Olympic rugby stadium than for her performances on the pitch

Teenager who scaled Trump Tower had past problems at home

Aug 11, 2016

A Virginia teenager who climbed partway up Trump Tower in New York City had a history of problems at home

Asian shares climb, tracking gains in US stocks, oil prices

Aug 12, 2016

Asian shares rose Friday, tracking the rally in U.S. stocks that was driven by strong gains by energy companies and retailers

Search

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: sales@deckbiz.com